605 related articles for article (PubMed ID: 28473248)
1. Endothelial deletion of mTORC1 protects against hindlimb ischemia in diabetic mice via activation of autophagy, attenuation of oxidative stress and alleviation of inflammation.
Fan W; Han D; Sun Z; Ma S; Gao L; Chen J; Li X; Li X; Fan M; Li C; Hu D; Wang Y; Cao F
Free Radic Biol Med; 2017 Jul; 108():725-740. PubMed ID: 28473248
[TBL] [Abstract][Full Text] [Related]
2.
López-Díez R; Shen X; Daffu G; Khursheed M; Hu J; Song F; Rosario R; Xu Y; Li Q; Xi X; Zou YS; Li H; Schmidt AM; Yan SF
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1536-1547. PubMed ID: 28642238
[TBL] [Abstract][Full Text] [Related]
3. mTORC1 and mTORC2 play different roles in the functional survival of transplanted adipose-derived stromal cells in hind limb ischemic mice via regulating inflammation in vivo.
Fan W; Cheng K; Qin X; Narsinh KH; Wang S; Hu S; Wang Y; Chen Y; Wu JC; Xiong L; Cao F
Stem Cells; 2013 Jan; 31(1):203-14. PubMed ID: 23081858
[TBL] [Abstract][Full Text] [Related]
4. Low molecular-weight fucoidan protects against hindlimb ischemic injury in type 2 diabetic mice through enhancing endothelial nitric oxide synthase phosphorylation.
Liu T; Wang Z; Chen X; You H; Xue J; Cai D; Zheng Y; Xu Y; Luo D
J Diabetes; 2018 Nov; 10(11):820-834. PubMed ID: 29633569
[TBL] [Abstract][Full Text] [Related]
5. Reduced Sirtuin1 signalling exacerbates diabetic mice hindlimb ischaemia injury and inhibits the protective effect of a liver X receptor agonist.
Fan W; Zhang R; Han D; Jiang Z; Li S; Zhang J; Li Y; Wang Y; Cao F
J Cell Mol Med; 2020 May; 24(10):5476-5490. PubMed ID: 32286000
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
[TBL] [Abstract][Full Text] [Related]
7. Deletion of AT2 Receptor Prevents SHP-1-Induced VEGF Inhibition and Improves Blood Flow Reperfusion in Diabetic Ischemic Hindlimb.
Paquin-Veillette J; Lizotte F; Robillard S; Béland R; Breton MA; Guay A; Despatis MA; Geraldes P
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2291-2300. PubMed ID: 29074590
[TBL] [Abstract][Full Text] [Related]
8. Sodium Tanshinone IIA sulfonate improves post-ischemic angiogenesis in hyperglycemia.
Chen L; He W; Peng B; Yuan M; Wang N; Wang J; Lu W; Wang T
Biochem Biophys Res Commun; 2019 Dec; 520(3):580-585. PubMed ID: 31623833
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of ghrelin in diabetes impairs the vascular reparative response to hindlimb ischemia in a mouse model; clinical relevance to peripheral artery disease.
Neale JPH; Pearson JT; Thomas KN; Tsuchimochi H; Hosoda H; Kojima M; Sato T; Jones GT; Denny AP; Daniels LJ; Chandrasekera D; Liu P; van Rij AM; Katare R; Schwenke DO
Sci Rep; 2020 Aug; 10(1):13651. PubMed ID: 32788622
[TBL] [Abstract][Full Text] [Related]
10. Anti-vascular endothelial growth factor treatment induces blood flow recovery through vascular remodeling in high-fat diet induced diabetic mice.
Xiao L; Yan K; Yang Y; Chen N; Li Y; Deng X; Wang L; Liu Y; Mu L; Li R; Luo M; Ren M; Wu J
Microvasc Res; 2016 May; 105():70-6. PubMed ID: 26808210
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic VEGF
Ganta VC; Choi M; Farber CR; Annex BH
Circulation; 2019 Jan; 139(2):226-242. PubMed ID: 30586702
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine improves the response to ischemic muscle injury and increases HMGB1 after arterial ligation.
Xu J; Cui X; Li J; Koutakis P; Pipinos I; Tzeng E; Chen A; Sachdev U
J Vasc Surg; 2018 Mar; 67(3):910-921. PubMed ID: 28259568
[TBL] [Abstract][Full Text] [Related]
13. Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice.
Iwabayashi M; Taniyama Y; Sanada F; Azuma J; Iekushi K; Kusunoki H; Chatterjee A; Okayama K; Rakugi H; Morishita R
Atherosclerosis; 2012 Feb; 220(2):337-42. PubMed ID: 22172591
[TBL] [Abstract][Full Text] [Related]
14. Trimethylamine N-oxide impairs perfusion recovery after hindlimb ischemia.
Chen L; Jin Y; Wang N; Yuan M; Lin T; Lu W; Wang T
Biochem Biophys Res Commun; 2020 Sep; 530(1):95-99. PubMed ID: 32828321
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mammalian target of rapamycin complex 1 in the brain microvascular endothelium ameliorates diabetic Aβ brain deposition and cognitive impairment via the sterol-regulatory element-binding protein 1/lipoprotein receptor-associated protein 1 signaling pathway.
Jiang G; Long Z; Wang Y; Wang Y; Xue P; Chen M; Yang K; Li W
CNS Neurosci Ther; 2023 Jul; 29(7):1762-1775. PubMed ID: 36890627
[TBL] [Abstract][Full Text] [Related]
16. Naoxintong restores collateral blood flow in a murine model of hindlimb ischemia through PPARδ-dependent mechanism.
Chen L; Zhang L; Fang Z; Li C; Yang Y; You X; Song M; Coffie J; Zhang L; Gao X; Wang H
J Ethnopharmacol; 2018 Dec; 227():121-130. PubMed ID: 30170078
[TBL] [Abstract][Full Text] [Related]
17. Glycaemic control improves perfusion recovery and VEGFR2 protein expression in diabetic mice following experimental PAD.
Dokun AO; Chen L; Lanjewar SS; Lye RJ; Annex BH
Cardiovasc Res; 2014 Mar; 101(3):364-72. PubMed ID: 24385342
[TBL] [Abstract][Full Text] [Related]
18. Silencing RIPK1/mTORC1 signalling attenuated the inflammation and oxidative stress in diabetic cardiomyopathy.
Liu Q; Deng C; Xing X; Hu Y; Wang Z; Liang Y
Exp Cell Res; 2023 Jan; 422(2):113417. PubMed ID: 36379276
[TBL] [Abstract][Full Text] [Related]
19. Use of p53-Silenced Endothelial Progenitor Cells to Treat Ischemia in Diabetic Peripheral Vascular Disease.
Kundu N; Domingues CC; Chou C; Ahmadi N; Houston S; Jerry DJ; Sen S
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28365567
[TBL] [Abstract][Full Text] [Related]
20. Endothelial progenitor cells derived from Wharton's jelly of the umbilical cord reduces ischemia-induced hind limb injury in diabetic mice by inducing HIF-1α/IL-8 expression.
Shen WC; Liang CJ; Wu VC; Wang SH; Young GH; Lai IR; Chien CL; Wang SM; Wu KD; Chen YL
Stem Cells Dev; 2013 May; 22(9):1408-18. PubMed ID: 23252631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
